Frank J. Hsu Brookline Capital Acquisition Corp. (BCAC) insider trading activity

BCAC Quotes by TradingView

Frank J. Hsu is Chief Medical Officer of Brookline Capital Acquisition Corp.. Currently has a direct ownership of 0 shares of BCAC, which is worth approximately $0. The most recent transaction as insider was on Aug 23, 2023, when has been sold 16,354 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Frank J. Hsu Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 23 2023
SELL
Sale (or disposition) back to the issuer
-
16,354 Reduced 100.0%
0 Common Stock
Jun 15 2023
SELL
Payment of exercise price or tax liability
$2,118 $0.49 p/Share
4,323 Reduced 20.91%
16,354 Common Stock
Dec 15 2022
SELL
Payment of exercise price or tax liability
$4,582 $1.06 p/Share
4,323 Reduced 17.29%
20,677 Common Stock
Oct 07 2022
BUY
Grant, award, or other acquisition
-
25,000 Added 50.0%
25,000 Common Stock
FJH

Frank J. Hsu

Chief Medical Officer
San Carlos, CA

Track Institutional and Insider Activities on BCAC

Follow Brookline Capital Acquisition Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCAC shares.

Notify only if

Insider Trading

Get notified when an Brookline Capital Acquisition Corp. insider buys or sells BCAC shares.

Notify only if

News

Receive news related to Brookline Capital Acquisition Corp.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCAC